About Us
ImmuneMed Inc. utilizes human's own immunity against Infectious Diseases. With the belief that it is the most basic solution, we have been researching for many years.
ImmuneMed Inc. utilizes human's own immunity against Infectious Diseases. With the belief that it is the most basic solution, we have been researching for many years.
ImmuneMed Inc. was established with the corporate goal of 'contributing to the healthy life of mankind free from infectious diseases.' We would like to ask our researchers who are working with the ever-day and night virus to open new horizons in medical history around the world.
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing and developing VSF (Virus Suppressing Factor), an antiviral source.
We are conducting research with the belief that leveraging human immunity is the most basic solution to various diseases. We are developing and developing VSF (Virus Suppressing Factor), an antiviral source.
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate
development of the treatment
2021-01-08
COVID-19 Phase 2 Clinical Study Approval (Italy), December 18th, 2020
2020-12-21
Obtaining Approval Letter of Investigational New Drug (IND) for COVID-19 Phase 2
Study in Republic of Korea on 7th December, 2020
2020-12-07
COVID-19 Phase 2 Clinical Study Approval (Indonesia), December 1st, 2020
2020-12-01